secwatch / observer
8-K filed March 1, 2023, 6:59 PM ET ticker BHC CIK 0000885590
leadership confidence high sentiment neutral materiality 0.30

Two directors to retire from Bausch Health board at 2023 annual meeting

Bausch Health Companies Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Argeris Karabelas

Director
BHC · Bausch Health Companies Inc.
Filed
March 1, 2023, 6:59 PM ET
On February 28, 2023, Mr. Richard De Schutter and Dr. Argeris Karabelas notified Bausch Health Companies Inc. (the “Company”) of their decision to retire as directors from the Board of Directors (the “Board”) of the Company, effective at the upcoming 2023 annual meeting of shareholders of the Company (the “2023 Annual Meeting”).
Departed

Richard De Schutter

Director
BHC · Bausch Health Companies Inc.
Filed
March 1, 2023, 6:59 PM ET
On February 28, 2023, Mr. Richard De Schutter and Dr. Argeris Karabelas notified Bausch Health Companies Inc. (the “Company”) of their decision to retire as directors from the Board of Directors (the “Board”) of the Company, effective at the upcoming 2023 annual meeting of shareholders of the Company (the “2023 Annual Meeting”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Argeris Karabelas retired as Director at Bausch Health Companies Inc..

Action
retired
Role
Director
Exact text from the filing
On February 28, 2023, Mr. Richard De Schutter and Dr. Argeris Karabelas notified Bausch Health Companies Inc. (the “Company”) of their decision to retire as directors from the Board of Directors (the “Board”) of the Company, effective at the upcoming 2023 annual meeting of shareholders of the Company (the “2023 Annual Meeting”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Richard De Schutter retired as Director at Bausch Health Companies Inc..

Action
retired
Role
Director
Exact text from the filing
On February 28, 2023, Mr. Richard De Schutter and Dr. Argeris Karabelas notified Bausch Health Companies Inc. (the “Company”) of their decision to retire as directors from the Board of Directors (the “Board”) of the Company, effective at the upcoming 2023 annual meeting of shareholders of the Company (the “2023 Annual Meeting”).
View on SEC.gov

Bausch Health Companies Inc. filing history →

Source: SEC EDGAR
accession 0000885590-23-000012
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.